Title: Prevalence and Clinical Profile of Anaemia in SLE
Authors: Srikantan Sreedharan Pillai, Shila Raj L.T
DOI: https://dx.doi.org/10.18535/jmscr/v6i3.155
Abstract
Background: SLE is the prototype of the autoimmune disease affecting predominantly women. Ninety percent of patients are women in the child bearing age. A number of studies have shown that haematological manifestations are common in SLE, of which anaemia is the most common. The cause of anaemia in SLE are multifactorial. The objective of this study was to estimate the prevalence and clinical profile of anaemia in SLE.
Materials and Methods: Our study was a descriptive type of hospital based cross sectional study.96 patients with SLE satisfying the inclusion criteria were included in the study. They were subjected to a detailed clinical examination and complete blood hemogram.
Results: Out of 96 patients taken up for the study, 47 patients (49%) had anaemia. Anaemia of chronic disease was the commonest type seen in 28.1% followed by iron deficiency in 10.4%.
Conclusion: Haematological manifestations are very common in SLE. Anaemia was present in 49% of patients. Anaemia of chronic disease was the predominant type followed by iron deficiency anaemia.
Keywords: SLE, SLEDAI .
References
- Malaviya AN, Chandrasekharan AN, Kumar A, et al. Occasional series –lupus around the world systemic lupus erythematosis in India. Lupus 1997; 6(9);690-700.
- Malaviya AN, SinghRR, Kumar A ,et al. Systemic lupus erythematosis in northern India; A Review of 329 cases. J . Assoc. Physicians India 1988;36(8);476-480
- Hochberg MC, Updating the American college of Rheumatology Revised Criteria for the classification of systemic lupus erythematosis. Arthritis Rheum.1997; 40(9);1725
- Symmons DP, Coppock JS, Bacon PA, et al. Development and assessment of a computerised index of clinical disease activity in systemic erythematosis. Members of the British Isles lupus assessment group (BILAG)Q J Med1988;69(259);927-937
- Alarcon-Segovia D,Deleze M, Oria CV,et al.Antiphospholipid antibodies and the antiphospholipid syndrome in systemic lupus erythematosis.A prospective analysis of 500 consecutive patients. Medicine (Baltimore)1989;68;353-365
- Hazeltine M ,Rauch J Danoff D, et al. Antiphospholipid antibodies in systemic lupus erythematosis; Evidence of an association with positive coombs and hypocomplementemia .J Rheumatol. 1988;15;80-86
- Schleider MA, Nachman RL Jaffe EA.et al. Clinical study of the lupus anticoagulant. Blood 1976;48;499-509
- Pereira RMR, Velloso ERP, Menezes Y, et al. Bone marrow findings in systemic lupus erythematosis patients with peripheral cytopenias. Clin. Rheumatol 1988;17;219-222
- Means RT, Krantz SB, Progress in understanding the pathogenesis of anaemia of chronic disease.Blood1992;80;1639-47
- Peeters HR, Jongen- Lavrrncic M, Bakker CH, et al. Recombinant human erythropoietin improves health related quality of life in patients with rheumatoid arthritis and anaemia of chronic disease. Rheumatol Int 1999;18;201-6
- Schreiber S,Howaldt S,Schnoor M, et al. Recombinant erythropoietin for the treatment of anaemia in inflammatory bowel disease. N Engl J Med1996; 334;619-623
- Casadevall N, Dupuy E,Molho-Sabatier P, et al. Auto antibodies against erythropo-ietin in a patient with pure red cell aplasia. N Engl J Med 1996;334;630-3
- Cervera R, Font J,Lopez –Soto A,et al. Isotope distribution of anticardiolipin antibodies in systemic lupus erythematosis; Prospective analysis of a series of 100 patients. Ann Rheum Dis1990;49;109-11.